Volgen
Daniel A. Green
Daniel A. Green
Scientific Leader, GlaxoSmithKline
Geverifieerd e-mailadres voor gsk.com
Titel
Geciteerd door
Geciteerd door
Jaar
Crystallisation of paracetamol (acetaminophen) in the presence of structurally related substances
BA Hendriksen, DJW Grant, P Meenan, DA Green
Journal of crystal growth 183 (4), 629-640, 1998
921998
L‐Tyrosine production by recombinant Escherichia coli: Fermentation optimization and recovery
R Patnaik, RR Zolandz, DA Green, DF Kraynie
Biotechnology and bioengineering 99 (4), 741-752, 2008
872008
Predicting the effect of solvent on the crystal habit of small organic molecules
CJ Tilbury, DA Green, WJ Marshall, MF Doherty
Crystal Growth & Design 16 (5), 2590-2604, 2016
692016
Perspectives on the current state, challenges, and opportunities in pharmaceutical crystallization process development
A Cote, D Erdemir, KP Girard, DA Green, MA Lovette, E Sirota, NK Nere
Crystal Growth & Design 20 (12), 7568-7581, 2020
662020
Extruded blends of chitosan and ethylene copolymers for antimicrobial packaging
DF Massouda, D Visioli, DA Green, RD Joerger
Packaging technology and science 25 (6), 321-327, 2012
212012
Crystallizer mixing: Understanding and modeling crystallizer mixing and suspension flow
D Green
Handbook of industrial crystallization, 181-199, 2002
212002
Multi-stage glycolic acid crystallization
FG Gallagher, RK Hackman, DA Green
US Patent 7,439,391, 2008
152008
Crystal growth of organic materials
AS Myerson, DA Green, P Meenan
131996
Sodium cyanide process
JM Rogers, DA Green
US Patent 6,896,863, 2005
122005
Acetaminophen crystal habit: Solvent effects
DA Green, P Meenan
Crystal growth of organic materials, 78-84, 1996
111996
Instabilities in self-fluidized beds—I theory
D Green, GM Homsy
International journal of multiphase flow 13 (4), 443-458, 1987
111987
Instabilities in self-fluidized beds—II experiments
D Green, GM Homsy
International journal of multiphase flow 13 (4), 459-475, 1987
101987
Cross-pharma collaboration for the development of a simulation tool for the model-based digital design of pharmaceutical crystallization processes (CrySiV)
B Szilagyi, WL Wu, A Eren, J Mackey, S Kshirsagar, E Szilagyi, ...
Crystal Growth & Design 21 (11), 6448-6464, 2021
92021
Continuous process for producing poly (trimethylene terephthalate)
JH Eng, EA Blum, DA Green, CJ Giardino, G Parrish, RE Trotter, ...
US Patent 7,531,617, 2009
82009
Apparatus and process used in growing crystals
DA Green
US Patent 7,122,083, 2006
72006
Method for preparing rare-earth doped fluoride nanoparticles
C Chi, DA Green, KR Mikeska, LA Silverman
US Patent 8,858,833, 2014
62014
Mineral characterization of fluidized-bed combustion aerosol ash--Montana Rosebud sub-bituminous coal
MH Mazza, DA Green, MW Paris, GJ Newton
Department of Energy, Morgantown, W. Va.(USA). Morgantown Energy Research Center, 1978
61978
Habit modelling and verification for glutaric acid
DA Green, P Meenan, GM Sunshine, BJ Ennis
Journal of Physics D: Applied Physics 26 (8B), B35, 1993
51993
Crystal engineering for product and process design
MF Doherty, DA Green
Computer Aided Chemical Engineering 24, 9, 2007
42007
NK Nere Perspectives on the Current State, Challenges, and Opportunities in Pharmaceutical Crystallization Process Development., 2020, 20
A Cote, D Erdemir, KP Girard, DA Green, MA Lovette, E Sirota
DOI: https://doi. org/10.1021/acs. cgd. 0c00847, 7568-7581, 0
4
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20